Early neuropsychiatry features in neuroferritinopathy

Movement Disorders

Volumn 28, Issue 9, 2013, Pages 1310-1313

  Keogh, Michael J ^a,b   Singh, Baldev ^c   Chinnery, Patrick F ^a,b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

^c TYNE AND WEAR NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; HALOPERIDOL; OLANZAPINE; RISPERIDONE;

AGGRESSION; AUTOSOMAL DOMINANT DISORDER; COGNITION; CORTICOBASAL DEGENERATION; DEGENERATIVE DISEASE; DEPRESSION; EXECUTIVE FUNCTION; FOLLOW UP; FRONTAL LOBE; GENE MUTATION; HUMAN; HUNTINGTON CHOREA; INSTITUTIONAL CARE; INVOLUNTARY MOVEMENT; LEARNING; LETTER; MENTAL INSTABILITY; MOTOR DYSFUNCTION; NEUROFERRITINOPATHY; NEUROPSYCHIATRY; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PSYCHOMETRY; SHORT TERM MEMORY; SYSTEMATIC REVIEW;

ADULT; COGNITION DISORDERS; FEMALE; HUMANS; IRON METABOLISM DISORDERS; MALE; MENTAL DISORDERS; MIDDLE AGED; NEUROAXONAL DYSTROPHIES;

EID: 84883552813     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25371     Document Type: Letter

References (8)

1. Curtis AR, Fey C, Morris CM, et al. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet. 2001;28:350-354.
2. Vidal R, Ghetti B, Takao M, et al. Intracellular ferritin accumulation in neural and extraneural tissue characterizes a neurodegenerative disease associated with a mutation in the ferritin light polypeptide gene. J Neuropathol Exp Neurol. 2004;63:363-380.
3. Barbeito AG, Garringer HJ, Baraibar MA, et al. Abnormal iron metabolism and oxidative stress in mice expressing a mutant form of the ferritin light polypeptide gene. J Neurochem. 2009; 109:1067-1078.
4. Maciel P, Cruz VT, Constante M, et al. Neuroferritinopathy: missense mutation in FTL causing early-onset bilateral pallidal involvement. Neurology. 2005;65:603-605.
5. Mancuso M, Davidzon G, Kurlan RM, et al. Hereditary ferritinopathy: a novel mutation, its cellular pathology, and pathogenetic insights. J Neuropathol Exp Neurol. 2005;64:280-294.
6. Devos D, Tchofo PJ, Vuillaume I, et al. Clinical features and natural history of neuroferritinopathy caused by the 458dupA FTL mutation. Brain. 2009;132:e109.
7. Brandt J, Shpritz B, Codori AM, Margolis R, Rosenblatt A. Neuropsychological manifestations of the genetic mutation for Huntington's disease in presymptomatic individuals. J Int Neuropsychol Soc. 2002;8:918-924.
8. Bak TH, Crawford LM, Hearn VC, Mathuranath PS, Hodges JR. Subcortical dementia revisited: similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA). Neurocase. 2005;11:268-273.